FMS vs. VEEV: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at FMS and VEEV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
FMS trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, VEEV is a standard domestic listing.
| Symbol | FMS | VEEV |
|---|---|---|
| Company Name | Fresenius Medical Care AG | Veeva Systems Inc. |
| Country | Germany | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Health Care Providers & Services | Health Care Technology |
| Market Capitalization | 14.58 billion USD | 45.62 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | September 17, 1996 | October 16, 2013 |
| Security Type | ADR | Common Stock |
Historical Performance
This chart compares the performance of FMS and VEEV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | FMS | VEEV |
|---|---|---|
| 5-Day Price Return | 2.02% | -0.21% |
| 13-Week Price Return | -17.32% | 15.63% |
| 26-Week Price Return | -11.70% | 16.60% |
| 52-Week Price Return | 20.91% | 50.57% |
| Month-to-Date Return | -7.06% | -1.77% |
| Year-to-Date Return | -6.39% | 32.78% |
| 10-Day Avg. Volume | 0.64M | 1.02M |
| 3-Month Avg. Volume | 0.56M | 1.40M |
| 3-Month Volatility | 22.56% | 42.27% |
| Beta | 0.60 | 0.97 |
Profitability
Return on Equity (TTM)
FMS
4.70%
Health Care Providers & Services Industry
- Max
- 26.03%
- Q3
- 13.74%
- Median
- 8.26%
- Q1
- 4.13%
- Min
- -3.62%
FMS’s Return on Equity of 4.70% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.
VEEV
13.74%
Health Care Technology Industry
- Max
- 47.95%
- Q3
- 35.17%
- Median
- 13.74%
- Q1
- 11.05%
- Min
- 11.05%
VEEV’s Return on Equity of 13.74% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
FMS
3.36%
Health Care Providers & Services Industry
- Max
- 12.40%
- Q3
- 5.93%
- Median
- 1.96%
- Q1
- 0.93%
- Min
- -6.10%
FMS’s Net Profit Margin of 3.36% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
VEEV
27.34%
Health Care Technology Industry
- Max
- 51.50%
- Q3
- 45.32%
- Median
- 27.34%
- Q1
- 14.21%
- Min
- 14.21%
VEEV’s Net Profit Margin of 27.34% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.
Operating Profit Margin (TTM)
FMS
7.57%
Health Care Providers & Services Industry
- Max
- 19.05%
- Q3
- 10.21%
- Median
- 4.22%
- Q1
- 1.98%
- Min
- -4.27%
FMS’s Operating Profit Margin of 7.57% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
VEEV
26.97%
Health Care Technology Industry
- Max
- 73.15%
- Q3
- 56.55%
- Median
- 26.97%
- Q1
- 22.10%
- Min
- 22.10%
VEEV’s Operating Profit Margin of 26.97% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.
Profitability at a Glance
| Symbol | FMS | VEEV |
|---|---|---|
| Return on Equity (TTM) | 4.70% | 13.74% |
| Return on Assets (TTM) | 2.02% | 11.20% |
| Net Profit Margin (TTM) | 3.36% | 27.34% |
| Operating Profit Margin (TTM) | 7.57% | 26.97% |
| Gross Profit Margin (TTM) | 24.67% | 75.50% |
Financial Strength
Current Ratio (MRQ)
FMS
1.44
Health Care Providers & Services Industry
- Max
- 2.01
- Q3
- 1.49
- Median
- 1.30
- Q1
- 0.94
- Min
- 0.17
FMS’s Current Ratio of 1.44 aligns with the median group of the Health Care Providers & Services industry, indicating that its short-term liquidity is in line with its sector peers.
VEEV
4.60
Health Care Technology Industry
- Max
- 7.04
- Q3
- 7.01
- Median
- 4.60
- Q1
- 2.96
- Min
- 0.31
VEEV’s Current Ratio of 4.60 aligns with the median group of the Health Care Technology industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
FMS
0.83
Health Care Providers & Services Industry
- Max
- 2.17
- Q3
- 1.18
- Median
- 0.74
- Q1
- 0.45
- Min
- 0.00
FMS’s Debt-to-Equity Ratio of 0.83 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
VEEV
0.00
Health Care Technology Industry
- Max
- 0.06
- Q3
- 0.05
- Median
- 0.01
- Q1
- 0.00
- Min
- 0.00
Falling into the lower quartile for the Health Care Technology industry, VEEV’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
FMS
5.73
Health Care Providers & Services Industry
- Max
- 14.47
- Q3
- 7.15
- Median
- 5.45
- Q1
- 2.04
- Min
- -4.44
FMS’s Interest Coverage Ratio of 5.73 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.
VEEV
169.00
Health Care Technology Industry
- Max
- 224.12
- Q3
- 222.84
- Median
- 219.00
- Q1
- 181.50
- Min
- 169.00
In the lower quartile for the Health Care Technology industry, VEEV’s Interest Coverage Ratio of 169.00 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.
Financial Strength at a Glance
| Symbol | FMS | VEEV |
|---|---|---|
| Current Ratio (MRQ) | 1.44 | 4.60 |
| Quick Ratio (MRQ) | 1.08 | 4.54 |
| Debt-to-Equity Ratio (MRQ) | 0.83 | 0.00 |
| Interest Coverage Ratio (TTM) | 5.73 | 169.00 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
FMS
3.48%
Health Care Providers & Services Industry
- Max
- 5.38%
- Q3
- 2.22%
- Median
- 0.55%
- Q1
- 0.00%
- Min
- 0.00%
With a Dividend Yield of 3.48%, FMS offers a more attractive income stream than most of its peers in the Health Care Providers & Services industry, signaling a strong commitment to shareholder returns.
VEEV
0.00%
Health Care Technology Industry
- Max
- 1.12%
- Q3
- 0.62%
- Median
- 0.12%
- Q1
- 0.00%
- Min
- 0.00%
VEEV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
FMS
187.56%
Health Care Providers & Services Industry
- Max
- 186.69%
- Q3
- 74.82%
- Median
- 26.76%
- Q1
- 0.00%
- Min
- 0.00%
At 187.56%, FMS’s Dividend Payout Ratio is exceptionally high, exceeding the typical range for the Health Care Providers & Services industry. While this provides a significant return to shareholders, it may limit funds for reinvestment and could be difficult to sustain.
VEEV
0.00%
Health Care Technology Industry
- Max
- 101.92%
- Q3
- 72.22%
- Median
- 42.51%
- Q1
- 0.00%
- Min
- 0.00%
VEEV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | FMS | VEEV |
|---|---|---|
| Dividend Yield (TTM) | 3.48% | 0.00% |
| Dividend Payout Ratio (TTM) | 187.56% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
FMS
18.48
Health Care Providers & Services Industry
- Max
- 55.89
- Q3
- 30.85
- Median
- 21.17
- Q1
- 12.63
- Min
- 0.00
FMS’s P/E Ratio of 18.48 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
VEEV
58.22
Health Care Technology Industry
- Max
- 343.51
- Q3
- 272.61
- Median
- 54.67
- Q1
- 36.04
- Min
- 31.57
VEEV’s P/E Ratio of 58.22 is within the middle range for the Health Care Technology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
FMS
0.62
Health Care Providers & Services Industry
- Max
- 3.10
- Q3
- 1.74
- Median
- 0.67
- Q1
- 0.24
- Min
- 0.00
FMS’s P/S Ratio of 0.62 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
VEEV
15.92
Health Care Technology Industry
- Max
- 176.90
- Q3
- 98.12
- Median
- 16.38
- Q1
- 4.49
- Min
- 0.00
VEEV’s P/S Ratio of 15.92 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
Price-to-Book Ratio (MRQ)
FMS
1.07
Health Care Providers & Services Industry
- Max
- 7.61
- Q3
- 4.32
- Median
- 2.53
- Q1
- 1.14
- Min
- 0.77
FMS’s P/B Ratio of 1.07 is in the lower quartile for the Health Care Providers & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
VEEV
6.13
Health Care Technology Industry
- Max
- 117.60
- Q3
- 90.72
- Median
- 8.09
- Q1
- 3.83
- Min
- 3.06
VEEV’s P/B Ratio of 6.13 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | FMS | VEEV |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 18.48 | 58.22 |
| Price-to-Sales Ratio (TTM) | 0.62 | 15.92 |
| Price-to-Book Ratio (MRQ) | 1.07 | 6.13 |
| Price-to-Free Cash Flow Ratio (TTM) | 6.02 | 38.33 |